产品描述
This human GP-IV ELISA kit employs the quantitative sandwich enzyme immunoassay technique to measure the levels of human GP-IV in multiple samples, including serum, plasma, or tissue homogenates. Antibody specific for GP-IV has been pre-coated onto the microplate. Standards and samples are pipetted into the wells and any GP-IV present is bound by the immobilized antibody. After removing any unbound substances, a biotin-conjugated GP-IV antibody is added to the wells. After washing, avidin conjugated HRP is added to the wells, forming an antibody-antigen-enzyme-labeled antibody complex. Following a wash to remove any unbound HRP-avidin, the TMB substrate solution is added to the wells, and the color develops into blue. The color changes from blue to yellow after the addition of stop solution into the wells. The color intensity is in proportion to the amount of GP-IV bound in the initial step.
GP-IV, also called CD36, is a scavenger receptor that plays a role in myocardial tissue uptake of long-chain fatty acids (FAs) and contributes to lipid accumulation and metabolic dysfunction when fat supply is excessive. CD36 is involved in immune modulation, metabolic regulation, and other pathophysiological processes. In renal tubular epithelial cells, CD36 promotes the uptake of AOPPs, resulting in lipotoxicity and renal tubule interstitial fibrosis in diabetic nephropathy. CD36 is related to platelet activation on the platelet. It is decreased in ischemia-reperfusion and pressure overload-caused cardiac hypertrophy but increased in diabetic cardiomyopathy and atherosclerosis.
别名
CD36; GP3B; GP4; Platelet glycoprotein 4; Fatty acid translocase; FAT; Glycoprotein IIIb; GPIIIB; Leukocyte differentiation antigen CD36; PAS IV; PAS-4; Platelet collagen receptor; Platelet glycoprotein IV; GPIV; Thrombospondin receptor; CD antigen CD36
缩写
CD36
Uniprot No
P16671
灵敏度
0.625 ng/mL
反应时间
1-5h
样本体积
50-100ul
检测波长
450 nm
研究领域
Immunology
测定原理
quantitative
精密度
| Intra-assay Precision (Precision within an assay): CV%<8% | | | |
| Three samples of known concentration were tested twenty times on one plate to assess. | |
| Inter-assay Precision (Precision between assays): CV%<10% | | | |
| Three samples of known concentration were tested in twenty assays to assess. | | |
| | | | | | | |
线性度
| To assess the linearity of the assay, samples were spiked with high concentrations of human GP-Ⅳ in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay. |
| | Sample | Serum(n=4) | |
| 1:1 | Average % | 90 | |
| Range % | 86-94 | |
| 1:2 | Average % | 104 | |
| Range % | 98-107 | |
| 1:4 | Average % | 91 | |
| Range % | 85-97 | |
| 1:8 | Average % | 97 | |
| Range % | 91-101 | |
回收率
| The recovery of human GP-Ⅳ spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section. |
|
| Sample Type | Average % Recovery | Range | |
| Serum (n=5) | 94 | 90-98 | |
| EDTA plasma (n=4) | 97 | 93-99 | |
| | | | | | | |
| | | | | | | |
标准曲线
| These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed. |
|
| ng/ml | OD1 | OD2 | Average | Corrected | | | 160 | 2.783 | 2.777 | 2.780 | 2.663 | | | 80 | 2.134 | 2.117 | 2.126 | 2.009 | | | 40 | 1.496 | 1.478 | 1.487 | 1.370 | | | 20 | 0.855 | 0.837 | 0.846 | 0.729 | | | 10 | 0.417 | 0.404 | 0.411 | 0.294 | | | 5 | 0.321 | 0.334 | 0.328 | 0.211 | | | 2.5 | 0.225 | 0.216 | 0.221 | 0.104 | | | 0 | 0.118 | 0.116 | 0.117 | | |
|
货期
3-5 working days